Biological Agents for the Treatment of Psoriasis

Psoriasis is a chronic autoimmune disease that affects the skin and joints. Biological agents have revolutionized the treatment of psoriasis by targeting specific molecules involved in the immune response. Here are some commonly used biological agents for the treatment of psoriasis:

Adalimumab: This agent targets tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in systemic inflammation. Adalimumab is used when other systemic treatments have failed and the disease is severe.

Brodalumab: This agent targets the interleukin 17 receptor found on CD8+ cytotoxic T cells. It is used when methotrexate or ciclosporin have failed.

Infliximab: This agent is also a TNF-alpha inhibitor, but it has been shown to reactivate latent tuberculosis. Therefore, it should be used with caution in patients with a history of tuberculosis.

Guselkumab: This agent targets interleukin 23, which is involved in the activation of T17 lymphocytes. It is used in the treatment of moderate to severe psoriasis.

Secukinumab: This agent targets interleukin 17, which is found on CD8+ cytotoxic T cells. It is used in the treatment of moderate to severe psoriasis.

Before starting any of these agents, certain criteria must be met, such as failure of other treatments and severity of the disease. Additionally, some agents may be contraindicated in patients with certain medical histories, such as a history of tuberculosis.

Atherosclerosis and Related Conditions

Atherosclerosis is a condition characterized by the accumulation of lipids in arterial walls, leading to the formation of atheromas. This process is often associated with hypercholesterolemia, where there is an increase in LDL cholesterol that can become oxidized and taken up by arterial wall LDL receptors. The oxidized LDL is then collected in macrophages, forming foam cells, which are precursors to atheromas. This process is exacerbated by hypertension, smoking, and diabetes, which can lead to the degradation of LDL to oxidized LDL and its uptake into arterial walls via scavenger receptors in macrophages.

Diabetes mellitus with hyperglycemia is also associated with the accumulation of sorbitol in tissues that do not require insulin for glucose uptake. This accumulation can contribute to the development of atherosclerosis. However, neutrophilic inflammation, which is often the result of infection, is not related to atherosclerosis and is unusual in arteries. Additionally, atherosclerosis is not a neoplastic process, although mutations can result in neoplastic transformation.

Overall, the process of atherogenesis is slow and does not involve significant inflammation or activation of complement. the underlying mechanisms of atherosclerosis and related conditions can help in the development of effective prevention and treatment strategies.

Lowering Cholesterol Levels: Dietary Changes to Consider

To lower cholesterol levels, it is important to make dietary changes. One effective change is to replace saturated fats with polyunsaturated fats. Saturated fats increase cholesterol levels, while unsaturated fats lower them. It is recommended to reduce the percentage of daily energy intake from fat, with a focus on reducing saturated fats. Increasing intake of foods such as pulses, legumes, root vegetables, and unprocessed cereals can also help lower cholesterol. Using a margarine containing an added stanol ester can increase plant stanol intake, which can also reduce cholesterol. However, reducing intake of dairy products and meat alone may not be as effective as replacing them with beneficial unsaturated fats. It is important to avoid replacing polyunsaturated fats with saturated fats, as this can raise cholesterol levels.

According to NICE guidelines, women over the age of 50 who experience regular symptoms such as abdominal bloating, loss of appetite, pelvic or abdominal pain, and increased urinary urgency and/or frequency should undergo serum CA125 testing. It is important to note that irritable bowel disease rarely presents for the first time in women over 50, so any symptoms suggestive of IBD should prompt appropriate tests for ovarian cancer. If serum CA125 levels are elevated, an ultrasound of the abdomen and pelvis should be arranged. If malignancy is suspected, urgent referral must be made. Physical examination may also warrant direct referral to gynaecology if ascites and/or a suspicious abdominal or pelvic mass is identified.

Ovarian cancer is a common malignancy in women, ranking fifth in frequency. It is most commonly diagnosed in women over the age of 60 and has a poor prognosis due to late detection. The majority of ovarian cancers, around 90%, are of epithelial origin, with serous carcinomas accounting for 70-80% of cases. Interestingly, recent research suggests that many ovarian cancers may actually originate in the distal end of the fallopian tube. Risk factors for ovarian cancer include a family history of BRCA1 or BRCA2 gene mutations, early menarche, late menopause, and nulliparity.

Clinical features of ovarian cancer are often vague and can include abdominal distension and bloating, abdominal and pelvic pain, urinary symptoms such as urgency, early satiety, and diarrhea. The initial diagnostic test recommended by NICE is a CA125 blood test, although this can also be elevated in other conditions such as endometriosis and benign ovarian cysts. If the CA125 level is raised, an urgent ultrasound scan of the abdomen and pelvis should be ordered. However, a CA125 test should not be used for screening asymptomatic women. Diagnosis of ovarian cancer is difficult and usually requires a diagnostic laparotomy.

Management of ovarian cancer typically involves a combination of surgery and platinum-based chemotherapy. Unfortunately, 80% of women have advanced disease at the time of diagnosis, leading to a 5-year survival rate of only 46%. It was previously thought that infertility treatment increased the risk of ovarian cancer due to increased ovulation, but recent evidence suggests that this is not a significant factor. In fact, the combined oral contraceptive pill and multiple pregnancies have been shown to reduce the risk of ovarian cancer by reducing the number of ovulations.

Overview of Cranial Nerves and Their Functions in Eye and Facial Movement

Cranial nerves play a crucial role in eye and facial movement. Cranial nerve VII, also known as the facial nerve, is affected in Bell’s palsy, causing a lower motor neuron VIIth nerve palsy that affects one side of the face. Cranial nerve IV, or the trochlear nerve, supplies the superior oblique muscle of the eye, and injury to this nerve causes vertical diplopia. Cranial nerve III, or the oculomotor nerve, supplies several muscles that control eye movement and the levator palpebrae superioris. Cranial nerve V, or the trigeminal nerve, provides sensation in the face and controls the muscles of mastication. Finally, cranial nerve VI, or the abducens nerve, supplies the lateral rectus muscle and lesions of this nerve cause lateral diplopia. Understanding the functions of these cranial nerves is essential in diagnosing and treating conditions that affect eye and facial movement.

The patient is presenting with thrombotic thrombocytopenic purpura (TTP), which is characterized by low platelet count due to clotting and platelet sequestration in small vessels. TTP is associated with haemolytic anaemia, thrombocytopenic purpura, fever, and neurological and renal abnormalities. The patient’s risk factors for TTP include being female, obese, pregnant, and of Afro-Caribbean origin. To determine the appropriate management, a urinary β-hCG test should be performed to establish pregnancy status. The first-line treatment for TTP is plasma exchange with fresh frozen plasma. Blood cultures should also be performed to check for underlying septicaemia. Antiplatelet antibody titres can be raised in idiopathic thrombocytopenic purpura (ITP), but ITP does not cause renal failure. A bone marrow study is appropriate to rule out leukaemia. Illicit drug use should also be considered as a cause of disseminated intravascular coagulation (DIC).

Patients who struggle with taking their antipsychotic medication as prescribed may benefit from receiving a once monthly intramuscular depo injection. It is important to maintain a stable mental state and overall well-being for these patients, and switching medications can increase the risk of relapse and recurring symptoms. The goal is to provide the least restrictive treatment possible and minimize hospitalization time as outlined by the Mental Health Act. While daily visits from a home treatment team to administer medication may be a temporary solution, it is not a sustainable long-term option. Similarly, a once-daily intramuscular injection may not be practical or feasible for the patient.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These medications have the advantage of significantly reducing extrapyramidal side-effects. However, they can also cause adverse effects such as weight gain, hyperprolactinaemia, and in the case of clozapine, agranulocytosis. The Medicines and Healthcare products Regulatory Agency has issued warnings about the increased risk of stroke and venous thromboembolism when antipsychotics are used in elderly patients. Examples of atypical antipsychotics include clozapine, olanzapine, risperidone, quetiapine, amisulpride, and aripiprazole.

Clozapine, one of the first atypical antipsychotics, carries a significant risk of agranulocytosis and requires full blood count monitoring during treatment. Therefore, it should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Adverse effects of clozapine include agranulocytosis, neutropaenia, reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

Achalasia is a condition where the lower esophageal sphincter fails to relax, causing difficulty in swallowing and regurgitation. Pneumatic dilation is a treatment option that involves using a balloon to stretch the sphincter and reduce pressure in the esophagus. However, this procedure carries a risk of perforation and is only recommended for patients who are good surgical candidates. Botulinum toxin A injections can also be used to inhibit the neurons that increase sphincter tone, but may require repeat treatments. Gastrostomy, or creating an artificial opening into the stomach, is reserved for severe cases where other treatments have failed and the patient is not a surgical candidate. Sublingual isosorbide dinitrate and nifedipine are pharmacological options that can temporarily relax the sphincter and may be used as a bridge while waiting for definitive treatment or for patients who cannot tolerate invasive procedures.

Biliary atresia is diagnosed when a newborn presents with prolonged jaundice, hepatomegaly, splenomegaly, abnormal growth, and cardiac murmurs. Surgery is the preferred treatment, specifically a hepatoportoenterostomy (HPE), also known as Kasai portoenterostomy. This procedure removes the blocked bile ducts and replaces them with a segment of the small intestine, restoring bile flow from the liver to the proximal small bowel. Ursodeoxycholic acid may be given as an adjuvant after surgery to facilitate bile flow and protect the liver. However, it should not be given if the total bilirubin is >256.6 micromol/L (>15 mg/dL). Frequent monitoring is not sufficient, urgent action is required. Liver transplant is not the first-line treatment, but may be considered if HPE is unsuccessful or if there are signs of end-stage liver disease, progressive cholestasis, hepatocellular decompensation, or severe portal hypertension.

Understanding Biliary Atresia in Neonatal Children

Biliary atresia is a condition that affects the extrahepatic biliary system in neonatal children, resulting in an obstruction in the flow of bile. This condition is more common in females than males and occurs in 1 in every 10,000-15,000 live births. There are three types of biliary atresia, with type 3 being the most common. Patients typically present with jaundice, dark urine, pale stools, and abnormal growth.

To diagnose biliary atresia, doctors may perform various tests, including serum bilirubin, liver function tests, serum alpha 1-antitrypsin, sweat chloride test, and ultrasound of the biliary tree and liver. Surgical intervention is the only definitive treatment for biliary atresia, and medical intervention includes antibiotic coverage and bile acid enhancers following surgery.

Complications of biliary atresia include unsuccessful anastomosis formation, progressive liver disease, cirrhosis, and eventual hepatocellular carcinoma. However, the prognosis is good if surgery is successful. In cases where surgery fails, liver transplantation may be required in the first two years of life. Overall, understanding biliary atresia is crucial for early diagnosis and effective management in neonatal children.

Differential Diagnosis for a Patient with Hypertensive Retinopathy

Hypertensive retinopathy is a serious condition that can lead to vision loss if left untreated. In this case, the patient has grade 4 hypertensive retinopathy according to the Keith-Wagener-Barker classification. The fundoscopy revealed bilateral optic disc swelling with cotton-wool spots, indicating optic neuropathy secondary to hypertension. Despite being on multiple medications to control hypertension, the patient’s blood pressure is difficult to manage.

While considering the diagnosis of hypertensive retinopathy, it is important to rule out other potential causes of the patient’s symptoms. An intracranial space-occupying lesion is not indicated in the patient’s history. Optic neuritis can present with loss of optic nerve function, but it is more commonly unilateral and does not typically involve cotton-wool spots. Pre-proliferative and proliferative diabetic retinopathy are also unlikely given the patient’s well-controlled type II diabetes.

In conclusion, the patient’s presentation is most consistent with hypertensive retinopathy. However, it is important to consider other potential diagnoses and rule them out through further evaluation and testing.

Febrile convulsions are commonly observed in children aged between 6 months to 5 years. The symptoms include a flushed and hot appearance followed by loss of consciousness. Febrile convulsions are usually characterized by tonic-clonic seizure-like episodes and a postictal period. Parents should be informed that most children experience only one episode. However, in children over 1-year-old who have had their first febrile convulsion, there is a 33% chance of recurrence, which is higher in children under 1. Although most children experience their first febrile convulsion by the age of 3, it can continue up to 5 years, especially in those who have had previous episodes. Children over 5 years old are less likely to experience febrile convulsions. If a child aged 7, 9, or 11 years experiences convulsions, they should be referred for neurological testing as it may indicate epilepsy.

Febrile convulsions are seizures caused by fever in children aged 6 months to 5 years. They typically last less than 5 minutes and are most commonly tonic-clonic. There are three types: simple, complex, and febrile status epilepticus. Children who have had a first seizure or any features of a complex seizure should be admitted to pediatrics. Regular antipyretics do not reduce the chance of a febrile seizure occurring. The overall risk of further febrile convulsion is 1 in 3, with risk factors including age of onset, fever duration, family history, and link to epilepsy. Children without risk factors have a 2.5% risk of developing epilepsy, while those with all three features have a much higher risk.

Understanding Thyroid Disorders: Differentiating Poor Compliance with Thyroxine from Other Conditions

Thyroid disorders can present with a variety of symptoms, making it important to differentiate between different conditions. In the case of poor compliance with thyroxine medication, a patient may present with signs of a low thyroid state, but blood results will show a high TSH and normal T4, indicating recent medication use.

Primary hypothyroidism, on the other hand, would show a low T4 and high TSH, while thyrotoxicosis would reveal a low TSH and high T4, accompanied by symptoms such as tachycardia and tremors. Secondary hypothyroidism would present with low levels of both T4 and TSH, indicating a pituitary problem.

Sick euthyroid syndrome, which often occurs in individuals with systemic illness, would show low levels of TSH, thyroxine, and T3, but the TSH level may still be within the normal range. Understanding these differences can help healthcare professionals make accurate diagnoses and provide appropriate treatment.

A pneumothorax is a condition where air accumulates in the pleural space between the parietal and visceral pleura. It can be primary or secondary, with the latter being more common in patients over 50 years old, smokers, or those with underlying lung disease. Symptoms include sudden chest pain, breathlessness, and, in severe cases, pallor, tachycardia, and hypotension. Primary spontaneous pneumothorax is more common in young adult smokers and often recurs. Secondary pneumothorax is associated with various lung diseases, including COPD and α-1-antitrypsin deficiency. A tension pneumothorax is a medical emergency that can lead to respiratory or cardiovascular compromise. Diagnosis is usually made through chest X-ray, but if a tension pneumothorax is suspected, treatment should be initiated immediately. Management varies depending on the size and type of pneumothorax, with larger pneumothoraces requiring aspiration or chest drain insertion. The safest location for chest drain insertion is the fifth intercostal space mid-axillary line within the safe triangle.

Calcium supplementation should only be prescribed alongside bisphosphonate treatment for osteoporosis if the patient’s dietary intake is insufficient.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.

Management of Intermittent Claudication in a Patient with Multiple Risk Factors

Intermittent claudication is a common symptom of arterial disease and can be caused by multiple risk factors, including smoking, diabetes, and hypercholesterolaemia. In managing a patient with intermittent claudication, it is important to first assess their ankle-brachial pressure index (ABPI) measurement to determine the severity of their arterial disease.

For patients with ABPI measurements between 0.6-0.9, first-line treatment involves managing risk factors and encouraging supervised exercise for three months. This patient should be optimally controlled for diabetes and compliant with their statin medication. Additionally, they should be prescribed 75 mg of clopidogrel daily to reduce the risk of blood clots.

A duplex USS arteriogram of both legs should be conducted to assess the extent of arterial disease. If necessary, a contrast-enhanced MRI may be used to plan revascularisation. However, surgery is typically only considered as a third-line treatment option.

It is important to note that analgesia is not the first-line treatment for intermittent claudication. Instead, addressing risk factors and enrolling in a supervised exercise programme for three months should be prioritised. Patients should be encouraged to exercise for two hours a week, to the maximum point of pain.

In summary, managing intermittent claudication in a patient with multiple risk factors involves a comprehensive approach that addresses risk factors, encourages exercise, and may involve further diagnostic testing and medication.

Methotrexate is known to cause mucositis, while lithium can lead to thyrotoxicosis but not oral ulcers. Levothyroxine may also cause thyrotoxicosis but not mouth ulcers. Atorvastatin does not typically cause mouth ulcers, with the most common side effects being myalgia and skin flushing. It is important to note that only methotrexate has mucositis listed as a side effect in the BNF.

Methotrexate: An Antimetabolite with Potentially Life-Threatening Side Effects

Methotrexate is an antimetabolite drug that inhibits the enzyme dihydrofolate reductase, which is essential for the synthesis of purines and pyrimidines. It is commonly used to treat inflammatory arthritis, psoriasis, and some types of leukemia. However, it is considered an important drug due to its potential for life-threatening side effects. Careful prescribing and close monitoring are essential to ensure patient safety.

The adverse effects of methotrexate include mucositis, myelosuppression, pneumonitis, pulmonary fibrosis, and liver fibrosis. The most common pulmonary manifestation is pneumonitis, which typically develops within a year of starting treatment and presents with non-productive cough, dyspnea, malaise, and fever. Women should avoid pregnancy for at least 6 months after treatment has stopped, and men using methotrexate need to use effective contraception for at least 6 months after treatment.

When prescribing methotrexate, it is important to follow guidelines and monitor patients regularly. Methotrexate is taken weekly, and FBC, U&E, and LFTs need to be regularly monitored. The starting dose is 7.5 mg weekly, and folic acid 5mg once weekly should be co-prescribed, taken more than 24 hours after the methotrexate dose. Only one strength of methotrexate tablet should be prescribed, usually 2.5 mg. It is also important to avoid prescribing trimethoprim or co-trimoxazole concurrently, as it increases the risk of marrow aplasia, and high-dose aspirin increases the risk of methotrexate toxicity.

In case of methotrexate toxicity, the treatment of choice is folinic acid. Methotrexate is a drug with a high potential for patient harm, and it is crucial to be familiar with guidelines relating to its use to ensure patient safety.

The primary treatment for theophylline toxicity is haemodialysis.

The presence of seizures and metabolic acidosis indicates that the pills ingested may contain theophylline. Theophylline can also lead to respiratory failure and ultimately, respiratory arrest, which explains the low pO2 levels. Confirmatory diagnosis can be made by measuring blood theophylline levels. While activated charcoal should be administered to all patients, regardless of the time of presentation, it is not the definitive treatment. Naloxone is specifically used for opiate toxicity.

Understanding Theophylline Toxicity and Its Management

Theophylline is a medication used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). However, it can also cause toxicity if not properly managed. The drug is metabolized by the cytochromes P450 enzymes located in the liver, which can be inhibited by acute illness and certain medications like ciprofloxacin and erythromycin. This inhibition can lead to the accumulation of theophylline in the body, causing toxicity.

The symptoms of theophylline toxicity include vomiting, agitation, dilated pupils, tachycardia, hyperglycemia, and hypokalemia. To manage the condition, acute levels should be measured as they correlate well with clinical severity. Regardless of the time of presentation, activated charcoal should be given to reduce absorption. Supportive management may include antiemetics, IV crystalloid for hypotension, correction of hypokalemia, benzodiazepines for seizures, and IV beta-blockers for supraventricular tachycardia (SVT). Definitive treatment is with hemodialysis.

In summary, understanding theophylline toxicity and its management is crucial for healthcare professionals who prescribe or administer the medication. Prompt recognition and appropriate management can prevent serious complications and improve patient outcomes.

Afferent Neurones

Afferent neurones are responsible for transmitting sensory signals from the periphery, such as receptors, organs, and other neurones, to the central nervous system, which includes the brain and spinal cord. These neurones are often referred to as sensory neurones. It is important to note that afferent neurones are not the same as bipolar, efferent, interneurone, or multipolar neurones.

Bipolar neurones are simply neurones that have only two extensions, such as those found in the retina or the ganglia of the vestibulocochlear nerve. Efferent neurones, on the other hand, transmit impulses from the central nervous system to the periphery, which is the opposite action of afferent neurones. Interneurones are neurones that connect afferent and efferent neurones in neural pathways. Finally, multipolar neurones are neurones that have a large number of dendrites, usually one long axon, and are found mostly in the brain and spinal cord for the integration of multiple incoming signals.

In summary, afferent neurones are responsible for transmitting sensory signals from the periphery to the central nervous system. They are distinct from other types of neurones, such as bipolar, efferent, interneurone, and multipolar neurones.

Treatment Options for a Patient with Narrow-Complex Tachycardia and Low Blood Pressure

When a patient with a history of ischaemic heart disease presents with a narrow-complex tachycardia and low blood pressure, it is likely that they have gone into fast atrial fibrillation. In this case, the first step in resuscitation should be a synchronised direct current (DC) cardioversion with a 150-J biphasic shock. Administering 100% oxygen, a 500 ml Hartmann bolus, and 0.5 mg metaraminol may help increase the patient’s blood pressure, but it does not address the underlying cause of their haemodynamic instability.

Amiodarone 300 mg stat is recommended for patients with narrow-complex tachycardia and haemodynamic instability. However, administering 10 mmol magnesium sulphate is not the first-line treatment for tachycardia unless the patient has torsades de pointes.

Lastly, administering Intralipid® as per guideline for local anaesthetic toxicity is unlikely to be the main source of the patient’s hypotension and does not address their narrow-complex tachycardia. Therefore, it is important to prioritize the synchronised cardioversion and amiodarone administration in this patient’s treatment plan.

Treatment Regime for Moderately Severe Eczema with Superimposed Infection

Moderately severe eczema with evidence of superimposed infection requires a specific treatment regime. The severity of eczema is categorized into four categories: clear, mild, moderate, and severe. In this case, the patient has small areas of dry skin mainly in the flexures, and there is evidence of infected eczema/cellulitis with an erythematosus, weeping patch of skin in the lateral thigh.

The treatment regime should include a regular emollient ointment, such as Diprobase®, applied generously to the skin multiple times a day. Additionally, a moderately potent topical corticosteroid, such as betamethasone valerate 0.025% or clobetasone butyrate 0.05%, should be used sparingly on the inflamed areas once a day. The patient must be advised to apply the steroid first and allow 15-20 minutes for it to be absorbed before applying the emollient. Treatment should last 7-14 days and continue until 48 hours after the eczematous patches have cleared.

Furthermore, oral antibiotics are necessary for the treatment of infected eczema. Oral flucloxacillin is considered first-line, and treatment usually lasts for a 10-day period.

Treatment Regime for Moderately Severe Eczema with Superimposed Infection

Understanding Dermatological Terms: Describing Skin Lesions

Accurately describing skin lesions is crucial in diagnosing skin conditions. Dermatological terms can help healthcare professionals communicate effectively about skin lesions. Here are some common terms:

– Bulla: A fluid-filled lesion (blister) that may be single or multiloculated.
– Crust: Dried serum, pus, or blood.
– Erythema: Vascular dilation and inflammation producing redness on the skin.
– Excoriation: Scratch marks, often self-induced and secondary to itching.
– Lichenification: Chronic thickening and increased marking of the skin caused by scratching.
– Macule: A change in color or texture of the skin without any change in elevation. When >1 cm in diameter, it is called a ‘patch.’
– Nodule: A raised lesion with a rounded surface greater than 0.5 cm in diameter.
– Papule: A solid, raised lesion less than 1 cm in diameter.
– Plaque: An elevated plateau of the skin, often greater than 0.5 cm.
– Pustule: A pus-filled lesion.
– Scale: Flakes arising from an abnormal stratum corneum.
– Telangiectasia: Small dilated blood vessels near the skin surface.
– Vesicle: A fluid-filled lesion less than 1 cm in diameter.
– Weal: A raised compressible area of dermal edema.

Understanding Dermatological Terms: Describing Skin Lesions

Understanding Achalasia: Symptoms, Diagnosis, and Differential Diagnosis

Achalasia is a motility disorder that affects the lower esophageal sphincter, causing difficulty swallowing both liquids and solids. This condition is characterized by the failure of the sphincter to relax in response to peristalsis during swallowing, which can lead to chest pain after eating and regurgitation of food. The cause of achalasia is unknown, but it is thought to be due to degeneration of the myenteric plexus.

To diagnose achalasia, a barium swallow may reveal a dilated esophagus with a bird’s beak tapering of the distal esophagus. Manometry can confirm the high-pressure, non-relaxing lower esophageal sphincter. Endoscopy should also be carried out to exclude malignancy.

Differential diagnosis for achalasia includes oesophageal carcinoma, pharyngeal pouch, benign oesophageal stricture, and caustic stricture. Oesophageal carcinoma is less likely in a relatively young patient without history of weight loss, and the barium swallow findings are more suggestive of achalasia than malignancy. A pharyngeal pouch would be visualized on a barium swallow, while a benign oesophageal stricture is more common in older people with a history of gastro-oesophageal reflux disease. Caustic stricture would also be visualized on a barium swallow, but there is no history of caustic damage in this case.

Oral Lesions: Differential Diagnosis and Characteristics

Oral lesions can present in a variety of forms and have different characteristics. In this case, a patient with a history of immunosuppression presents with a white mass on the lateral aspect of the tongue that cannot be scraped off with a tongue blade. This is most consistent with oral hairy leukoplakia, a non-premalignant Epstein-Barr virus-mediated mucocutaneous manifestation that often presents in immunosuppressed patients. Treatment involves antivirals.

Other possible oral lesions include oral discoid lupus erythematosus, which is the oral manifestation of systemic lupus erythematosus and typically presents as punched-out lesions with surrounding erythema. Aphthous ulcers are round or oval-shaped lesions with surrounding erythema that typically occur on the inside of the mouth and can be treated with topical steroids. Oral candidiasis can be scraped off with a tongue blade, making it an unlikely diagnosis in this case. Oral lichen planus is a chronic inflammatory condition that can present as white, lacy patches or erosions on the gingival margin.

In summary, a thorough examination and consideration of the patient’s medical history are necessary to accurately diagnose and treat oral lesions.

The initial treatment for blepharitis involves the use of hot compresses. Blepharitis is a common inflammatory condition that affects the margins of the eyelids. Symptoms of this condition include burning, itching, and crusting of the eyelids, which are often worse in the mornings and aggravated by makeup and wind. Both eyelids are typically affected, and patients may experience recurrent hordeolum or styes, as well as intolerance to contact lenses. While blepharitis cannot be cured, hot compresses and eyelid hygiene measures should be used twice daily to reduce the frequency and severity of relapses. Oral antibiotics are only used as a secondary option for patients who have not responded to hygiene measures and who have meibomian gland dysfunction and rosacea. If hygiene measures are ineffective, topical antibiotics like chloramphenicol may be prescribed. However, topical steroids such as dexamethasone drops are not recommended for the treatment of blepharitis.

Blepharitis is a condition where the eyelid margins become inflamed. This can be caused by dysfunction of the meibomian glands (posterior blepharitis) or seborrhoeic dermatitis/staphylococcal infection (anterior blepharitis). It is more common in patients with rosacea. The meibomian glands secrete oil to prevent rapid evaporation of the tear film, so any problem affecting these glands can cause dryness and irritation of the eyes. Symptoms of blepharitis are usually bilateral and include grittiness, discomfort around the eyelid margins, sticky eyes in the morning, and redness of the eyelid margins. Styes and chalazions are also more common in patients with blepharitis, and secondary conjunctivitis may occur.

Management of blepharitis involves softening the lid margin with hot compresses twice a day and practicing lid hygiene to remove debris from the lid margins. This can be done using cotton wool buds dipped in a mixture of cooled boiled water and baby shampoo or sodium bicarbonate in cooled boiled water. Artificial tears may also be given for symptom relief in people with dry eyes or an abnormal tear film.

Urinary Metabolites as Diagnostic Markers for Adrenal Disorders

Adrenal disorders such as phaeochromocytomas, congenital adrenal hyperplasia, and Cushing syndrome can be diagnosed by measuring specific urinary metabolites. For example, metanephrines, vanillylmandelic acid (VMA), and homovanillic acid (HVA) are the principal metabolic products of adrenaline and noradrenaline, and their elevated levels in urine indicate the presence of phaeochromocytomas. Similarly, increased urinary excretion of pregnanetriol and dehydroepiandrosterone are indicative of congenital adrenal hyperplasia. Free urinary cortisol levels are elevated in Cushing syndrome, which is characterized by weight gain, fatty tissue deposits, and other symptoms. Additionally, increased urinary excretion of 5-hydroxyindoleacetic acid is seen in functioning carcinoids. However, it is important to note that elevated levels of these metabolites can also occur in other conditions such as extreme stress states or medication use. Therefore, careful interpretation of urinary metabolite levels is necessary for accurate diagnosis of adrenal disorders.

Differential Diagnosis for a Patient with Pulmonary Oedema

The patient in question is likely suffering from flash pulmonary oedema, which can be caused by mitral valve regurgitation due to mitral valve disease. This is supported by the patient’s advanced age, hypertension, hyperlipidaemia, and the presence of a new systolic murmur at the apex. The backup of blood into the left atrium and pulmonary vasculature can lead to transudation of fluid into the pulmonary alveolar space, causing pulmonary oedema.

While pericardial effusion could also lead to pulmonary congestion, it would likely manifest with Beck’s triad of distant heart sounds, hypotension, and distended neck veins. Pleural effusion, on the other hand, would result in quieter sounds on auscultation and dullness to percussion. Lobar pneumonia would be accompanied by a fever and crackles on auscultation, but would not explain the new systolic murmur. Finally, left ventricular outflow tract obstruction, such as aortic stenosis, would cause a different type of murmur at the right upper sternal border, which is not present in this case.

Differentiating Glomerulonephritis and Other Possible Causes of Haematuria in a Young Patient

Haematuria in a young patient can be caused by various conditions, including glomerulonephritis, post-streptococcal glomerulonephritis, minimal change disease, sexually transmitted infections, and bladder cancer. IgA nephropathy, also known as Berger’s Disease, is the most common glomerulonephritis in the developed world and commonly affects young men. It presents with macroscopic haematuria a few days after a viral upper respiratory tract infection. A renal biopsy will show IgA deposits in the mesangium, and treatment is with steroids or cyclophosphamide if renal function is deteriorating.

Post-streptococcal glomerulonephritis, on the other hand, presents in young children usually one to two weeks post-streptococcal infection with smoky urine and general malaise. Proteinuria is also expected in a glomerulonephritis. Minimal change disease is the most common cause of nephrotic syndrome in children and is associated with an upper respiratory tract infection. However, nephrotic syndrome involves proteinuria, which this patient does not have.

It is also important to exclude sexually transmitted infections, as many are asymptomatic, but signs of infection and inflammation would likely show up on urine dipstick. Bladder cancer is unlikely in such a young patient devoid of other symptoms. Therefore, a thorough evaluation and proper diagnosis are necessary to determine the underlying cause of haematuria in a young patient.

Levothyroxine can be added to continue amiodarone in cases of amiodarone-induced hypothyroidism. This patient is exhibiting symptoms of hypothyroidism, which can occur in around 1 in 6 patients taking amiodarone. Amiodarone’s high iodine content can inhibit thyroxine production, leading to hypothyroidism. However, amiodarone can usually be continued alongside levothyroxine to counteract this effect. As the patient’s AF is currently being effectively controlled by amiodarone, it would be inappropriate to switch to digoxin, dronedarone, or flecainide, as these medications would require a period of re-titration and assessment that could increase the risk of stroke due to the AF. Additionally, amiodarone is preferred in patients with structural heart disease, which this patient has due to her heart failure.

Amiodarone and Thyroid Dysfunction

Amiodarone is a medication used to treat heart rhythm disorders. However, around 1 in 6 patients taking amiodarone develop thyroid dysfunction. This can manifest as either amiodarone-induced hypothyroidism (AIH) or amiodarone-induced thyrotoxicosis (AIT).

The pathophysiology of AIH is thought to be due to the high iodine content of amiodarone causing a Wolff-Chaikoff effect. This is an autoregulatory phenomenon where thyroxine formation is inhibited due to high levels of circulating iodide. Despite this, amiodarone may be continued if desirable.

On the other hand, AIT may be divided into two types: type 1 and type 2. Type 1 is caused by excess iodine-induced thyroid hormone synthesis, while type 2 is caused by amiodarone-related destructive thyroiditis. In patients with AIT, amiodarone should be stopped if possible.

It is important for healthcare professionals to monitor patients taking amiodarone for any signs of thyroid dysfunction and adjust treatment accordingly.

The presence of an ejection systolic murmur in this patient suggests that they may have Turner syndrome, which is known to cause complications such as bicuspid aortic valve. This can lead to aortic stenosis and result in the murmur. It is important to note that Turner’s syndrome does not typically affect lung development, and a mid-diastolic murmur would not be expected as a result of this condition.

Understanding Turner’s Syndrome

Turner’s syndrome is a genetic disorder that affects approximately 1 in 2,500 females. It is caused by the absence of one sex chromosome (X) or a deletion of the short arm of one of the X chromosomes. This condition is denoted as 45,XO or 45,X.

The features of Turner’s syndrome include short stature, a shield chest with widely spaced nipples, a webbed neck, a bicuspid aortic valve (15%), coarctation of the aorta (5-10%), primary amenorrhea, cystic hygroma (often diagnosed prenatally), a high-arched palate, a short fourth metacarpal, multiple pigmented naevi, lymphoedema in neonates (especially feet), and elevated gonadotrophin levels. Hypothyroidism is much more common in Turner’s syndrome, and there is also an increased incidence of autoimmune disease (especially autoimmune thyroiditis) and Crohn’s disease.

In summary, Turner’s syndrome is a chromosomal disorder that affects females and can cause a range of physical features and health issues. Early diagnosis and management can help individuals with Turner’s syndrome lead healthy and fulfilling lives.

When a newborn baby’s hearing test at birth shows an abnormal result, they are offered an auditory brainstem response test as a follow-up. This test involves placing electrodes on the baby’s scalp to measure their auditory evoked potentials in response to sounds. If there is no response, it may indicate reduced hearing ability.

It is not appropriate to use a distraction test on a newborn as they are not yet developed enough for this type of testing. This test is typically used for toddlers aged 6-9 months and requires two staff members. The test involves producing sounds to the right or left of the baby, out of their field of view, and assessing the loudness required for them to react.

Newborn otoacoustic emission testing is the initial screening assessment for hearing in newborns. However, this is only a screening test and further investigations are required to confirm any hearing loss. The test works by generating a click sound through an earpiece and measuring for the presence of a soft echo, which indicates a healthy cochlea.

Pure tone audiometry is not an appropriate second-line hearing investigation for newborns. This test requires the participant to indicate when they hear specific sounds and is typically used in school-aged children. Therefore, it is not useful for newborns.

Hearing Tests for Children

Hearing tests are important for children to ensure that they are developing normally. There are several tests that may be performed on children of different ages. For newborns, an otoacoustic emission test is typically done as part of the Newborn Hearing Screening Programme. This test involves playing a computer-generated click through a small earpiece and checking for the presence of a soft echo, which indicates a healthy cochlea. If the results of this test are abnormal, an Auditory Brainstem Response test may be done.

For infants between 6-9 months, a Distraction test may be performed by a health visitor with the help of two trained staff members. For children between 18 months to 2.5 years, a Recognition of familiar objects test may be used, which involves using familiar objects like a teddy or cup and asking the child simple questions like where is the teddy? For children over 2.5 years, Performance testing and Speech discrimination tests may be used, such as the Kendall Toy test or McCormick Toy Test. Pure tone audiometry is typically done at school entry in most areas of the UK for children over 3 years old.

In addition to these tests, there is also a questionnaire for parents in the Personal Child Health Records called Can your baby hear you? It is important for parents to be aware of these tests and to have their child’s hearing checked regularly to ensure proper development.